Dionysios C Watson

7PUBLICATIONS
61CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Separation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.

Juyeun Lee, Michael Nicosia, Ellen S Hong

|Sep 20, 2022
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.

Defne Bayik, Cynthia F Bartels, Katreya Lovrenert

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

|Apr 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.

Defne Bayik, Yadi Zhou, Chihyun Park

|Mar 15, 2018
Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes.

Dionysios C Watson, Bryant C Yung, Cristina Bergamaschi

|Feb 24, 2018
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.

Dionysios C Watson, Eirini Moysi, Antonio Valentin

Pageof 2